다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
캐나다
CSE
MindBio Therapeutics Corp (MBIO)
MindBio Therapeutics Corp (MBIO) 뉴스

MBIO

MindBio Therapeutics (MBIO)

MindBio Therapeutics Corp

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:CSE:MBIO

1

일자	시간	출처	헤드라인	심볼	기업
2023/08/24	22:00	InvestorsHub NewsWire	Mindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With Depression	CSE:MBIO	MindBio Therapeutics Corp
2023/06/14	21:00	InvestorsHub NewsWire	MindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of Sleep	CSE:MBIO	MindBio Therapeutics Corp
2023/05/30	21:00	InvestorsHub NewsWire	MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale	CSE:MBIO	MindBio Therapeutics Corp
2023/05/23	21:15	InvestorsHub NewsWire	MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder	CSE:MBIO	MindBio Therapeutics Corp
2023/05/11	21:29	InvestorsHub NewsWire	MindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional Distress	CSE:MBIO	MindBio Therapeutics Corp
2023/05/09	22:13	InvestorsHub NewsWire	MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants	CSE:MBIO	MindBio Therapeutics Corp

검색 관련기사 보기:CSE:MBIO

1

Municipal Income Opportu...

Battery Future Acquisition

Vontobel Financial Produ...

Vontobel Financial Produ...

SG Issuer Societe Generale

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관